# US 2020/0370070 A1 · Compositions and methods for efficient genome editing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0370070 A1
- Document ID: US20200370070A1
- Status: Published application
- Kind: A1
- Application number: 16/763,827
- Filed: 2018-11-19
- Published: 2020-11-26
- Earliest claimed: 2017-11-17
- Assignees: The Johns Hopkins University
- Applicants: The Johns Hopkins University
- Inventors: Geraldine Seydoux; Alexandre Paix
- Web page: https://patentgrep.com/patent/US20200370070A1

## CPC

- C12N 15/907: {in mammalian cells}
- C12N 15/873: Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- C12N 15/88: using microencapsulation, e.g. using {amphiphile} liposome vesicle
- C12N 15/90: Stable introduction of foreign DNA into chromosome
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to the field of genome editing. More specifically, the present invention provides compositions and methods useful in clustered regularly interspaced short palindromic repeats (CRISPR)-based techniques. In one embodiment, the present invention provides a double-stranded, linear donor polynucleotide comprising a template polynucleotide flanked by a first homology arm and a second homology arm, wherein the homology arms are between 30-35 bases in length.

## Claims

### Claim 1

A double-stranded, linear donor polynucleotide comprising a polynucleotide encoding a fluorescent protein flanked by a first homology arm and a second homology arm.

### Claim 2 (depends on 1)

The polynucleotide of claim 1, wherein the homology arms are 15-60 bases in length.

### Claim 3 (depends on 1)

The polynucleotide of claim 1, wherein the homology arms are 25-45 bases in length.

### Claim 4 (depends on 1)

The polynucleotide of claim 1, wherein the homology arms are 30-40 bases in length.

### Claim 5

A double-stranded, linear donor polynucleotide comprising a polynucleotide encoding a fluorescent protein flanked by a first homology arm and a second homology arm, wherein the first and second homology arms are between 30-35 bases in length.

### Claim 6

A double-stranded, linear donor polynucleotide comprising a template polynucleotide encoding an edit flanked by an intervening sequence and two homology arms.

### Claim 7 (depends on 6)

The polynucleotide of claim 6, wherein the homology arms are 15-60 bases in length.

### Claim 8 (depends on 6)

The polynucleotide of claim 6, wherein the homology arms are 25-45 bases in length.

### Claim 9 (depends on 6)

The polynucleotide of claim 6, wherein the homology arms are 30-40 bases in length.

### Claim 10 (depends on 6)

The polynucleotide of claim 6, wherein the template polynucleotide is up to 1 kb in length.

### Claim 11 (depends on 6)

The polynucleotide of claim 6, wherein the template polynucleotide comprises a sequence designed to change at least one nucleotide base within 30 bases of a double-stranded break (DSB) of a target nucleic acid.

### Claim 12 (depends on 11)

The polynucleotide of claim 11, wherein the template polynucleotide further comprises a restriction enzyme site.

### Claim 13

A double-stranded, linear donor polynucleotide comprising a template polynucleotide flanked by a first homology arm and a second homology arm, wherein the homology arms are between 30-35 bases in length.

### Claim 14 (depends on 14)

The polynucleotide of claim 14, wherein the template polynucleotide is up to 1 kb in length.

### Claim 15 (depends on 14)

The polynucleotide of claim 14, wherein the template polynucleotide comprises a sequence designed to change at least one nucleotide base within 30 bases of a DSB of a target nucleic acid.

### Claim 16 (depends on 15)

The polynucleotide of claim 15, wherein the template polynucleotide further comprises a restriction enzyme site.

### Claim 17 (depends on 6)

A method comprising the step of performing a clustered regularly interspaced short palindromic repeats (CRISPR)-based technique using a double-stranded, linear donor polynucleotide of claim 6 as the donor polynucleotide.

### Claim 18 (depends on 6)

A method comprising injecting into a target cell a composition comprising (a) an RNA-guided DNA endonuclease; (b) a guide RNA; and (c) a double-stranded, linear donor polynucleotide of claim 6.
